Sponsored in part by Amgen Oncology and Sanofi. Content independently created by OncLive.
Joseph Mikhael, MD, and panelists present a case of a 63-year-old woman with early relapse multiple myeloma and discuss the impact of updated trial data on treatment decision-making for patients.
EP. 5: Final Thoughts on Case Study and Treating Multiple MyelomaJanuary 12th 2023
Dr Joseph Mikhael and expert panel re-visit the patient case and offer their final thoughts on the impact of clinical trial updates in the treatment landscape of multiple myeloma.